Order Article Reprints

Kobayashi N, Miura K, Kaneko A, Matsumoto H, Somekawa K, Hirose T, Kajita Y, Tanaka A, Teranishi S, Sairenji Y, et al. Tailoring Therapeutic Strategies in Non-Small-Cell Lung Cancer: The Role of Genetic Mutations and Programmed Death Ligand-1 Expression in Survival Outcomes. Cancers. 2023; 15(21):5248. https://doi.org/10.3390/cancers15215248

Kobayashi, Nobuaki, Kenji Miura, Ayami Kaneko, Hiromi Matsumoto, Kohei Somekawa, Tomofumi Hirose, Yukihito Kajita, Anna Tanaka, Shuhei Teranishi, Yu Sairenji, and et al. 2023. "Tailoring Therapeutic Strategies in Non-Small-Cell Lung Cancer: The Role of Genetic Mutations and Programmed Death Ligand-1 Expression in Survival Outcomes" Cancers 15, no. 21: 5248. https://doi.org/10.3390/cancers15215248

Kobayashi, N., Miura, K., Kaneko, A., Matsumoto, H., Somekawa, K., Hirose, T., Kajita, Y., Tanaka, A., Teranishi, S., Sairenji, Y., Kawashima, H., Yumoto, K., Tsukahara, T., Fukuda, N., Nishihira, R., Kudo, M., Miyazawa, N., & Kaneko, T. (2023). Tailoring Therapeutic Strategies in Non-Small-Cell Lung Cancer: The Role of Genetic Mutations and Programmed Death Ligand-1 Expression in Survival Outcomes. Cancers, 15(21), 5248. https://doi.org/10.3390/cancers15215248